Literature DB >> 2475188

Leg ulcers in patients with sickle cell disease.

M Koshy1, R Entsuah, A Koranda, A P Kraus, R Johnson, R Bellvue, Z Flournoy-Gill, P Levy.   

Abstract

During the entry examination, leg ulcers were present in 2.5% of 2,075 patients 10 years of age and older with sickle cell disease who entered into the Cooperative Study of Sickle Cell Disease (CSSCD) between 1979 and 1986. Prevalence rates were highest among patients with sickle cell anemia and sickle cell anemia with thalassemia genotypes. Among sickle cell anemia patients free of ulcers at entry, the overall incidence was 5.73 per 100 person years in those having associated alpha-thalassemia and 9.97 for those without. Among sickle cell anemia patients with two alpha genes, the estimated incidence of leg ulcers is 2.38 per 100 person years and 6.12 per 100 person years among sickle cell anemia patients with three alpha genes (P less than .05). In both groups, the incidence was highest among those patients over 20 years of age and considerably higher among males than females (P less than .001). Leg ulcers were nonexistent in patients with sickle beta plus thalassemia and sickle hemoglobin C disease. Low steady-state hemoglobin is associated with a higher incidence of ulcer formation (P less than .0001) in sickle cell anemia patients. The protective effect of hemoglobin F is apparent at all levels of total hemoglobin among sickle cell anemia patients and those with associated alpha-thalassemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475188

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Laboratory and echocardiography markers in sickle cell patients with leg ulcers.

Authors:  Caterina P Minniti; James G Taylor; Mariana Hildesheim; Patricia O'Neal; Jonathan Wilson; Oswaldo Castro; Victor R Gordeuk; Gregory J Kato
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

2.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

Review 3.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 4.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

5.  Leg ulcers in sickle cell disease.

Authors:  Caterina P Minniti; James Eckman; Paola Sebastiani; Martin H Steinberg; Samir K Ballas
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

Review 6.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

Review 7.  Leg Ulcers in Sickle-Cell Disease: Treatment Update.

Authors:  Jean-Benoît Monfort; Patricia Senet
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-04-24       Impact factor: 4.730

Review 8.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

9.  Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients.

Authors:  Oluwagbemiga O Ayoola; Rahman A Bolarinwa; Uvie U Onakpoya; Tewogbade A Adedeji; Chidiogo C Onwuka; Bukunmi M Idowu
Journal:  Blood Adv       Date:  2018-11-27

10.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.